Skip to content

PHARMACIE NEUVE: what changed

BE 0475.096.003NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€7,599
2024 · €45,596-€37,997
Equity
€211,892
2024 · €205,126+€6,766
Cash
€83,833
2024 · €126,633-€42,800
Balance sheet total
€530,084
2024 · €612,368-€82,284

Largest movements

2024 to 2025
Assets
  • Cash -€42,800

    down €42,800 (-33.8%), from €126,633 to €83,833

    mainly Debts after one year (-€46,618) and Other debts (-€28,938)

  • Tangible fixed assets -€32,382

    down €32,382 (-15.9%), from €203,241 to €170,859

    of which Plant, machinery and equipment: -€26,284

  • Receivables within one year +€25,373

    up €25,373 (+19.4%), from €130,761 to €156,135

    of which Trade receivables: +€17,639

  • Stocks and contracts -€15,997

    down €15,997 (-15.4%), from €103,722 to €87,725

  • Intangible fixed assets -€11,800

    down €11,800 (-28.4%), from €41,575 to €29,775

Equity and liabilities
  • Debts after one year -€46,618

    down €46,618 (-30.5%), from €153,059 to €106,441

  • Other debts -€28,938

    down €28,938 (-34.1%), from €84,896 to €55,958

  • Current portion of long-term debt -€10,029

    down €10,029 (-17.7%), from €56,647 to €46,618

  • Reserves +€7,000

    up €7,000 (+3.8%), from €185,860 to €192,860

Income statement
  • Gross operating margin -€39,316

    down €39,316 (-16.8%), from €233,827 to €194,511

  • Staff costs +€15,506

    up €15,506 (+13.8%), from €112,265 to €127,771

  • Taxes -€14,189

    down €14,189 (-79.8%), from €17,786 to €3,597

  • Financial charges -€3,576

    down €3,576 (-29.8%), from €11,996 to €8,420

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €45,596
Gross operating margin -€39,316
Staff costs -€15,506
Depreciation -€91
Other operating charges +€203
Other operating items -€1,159
Financial income +€107
Financial charges +€3,576
Taxes +€14,189
Result 2025 €7,599
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€15,340
Investment -€660
Financing -€57,480
Cash 2024 €126,633
Net result for the year +€7,599
Depreciation +€44,842
Stocks and contracts +€15,997
Receivables within one year -€25,373
Deferred charges and accrued income +€4,679
Trade debts +€3,464
Tax, wage and social debts -€6,090
Other debts -€28,938
Accrued charges and deferred income -€839
Investment in fixed assets (net) -€660
Debts after one year -€46,618
Current portion of long-term debt -€10,029
Contributions, distributions and other -€833
Cash 2025 €83,833
brings cash intakes cash out
Every line side by side 47 lines
Line Code 2024 2025 Change %
Total assets 20/58 €612,368 €530,084 -€82,284 -13.4%
Fixed assets 21/28 €244,816 €200,634 -€44,182 -18.0%
Intangible fixed assets 21 €41,575 €29,775 -€11,800 -28.4%
Tangible fixed assets 22/27 €203,241 €170,859 -€32,382 -15.9%
Land and buildings 22 €9,916 €9,916 = 0.0%
Plant, machinery and equipment 23 €175,419 €149,135 -€26,284 -15.0%
Furniture and vehicles 24 €17,906 €11,809 -€6,097 -34.1%
Current assets 29/58 €367,553 €329,450 -€38,103 -10.4%
Stocks and contracts in progress 3 €103,722 €87,725 -€15,997 -15.4%
Stocks 30/36 €103,722 €87,725 -€15,997 -15.4%
Amounts receivable within one year 40/41 €130,761 €156,135 +€25,373 +19.4%
Trade receivables 40 €124,121 €141,760 +€17,639 +14.2%
Other amounts receivable 41 €6,641 €14,375 +€7,734 +116%
Cash at bank and in hand 54/58 €126,633 €83,833 -€42,800 -33.8%
Deferred charges and accrued income 490/1 €6,436 €1,758 -€4,679 -72.7%
Total equity and liabilities 10/49 €612,368 €530,084 -€82,284 -13.4%
Equity 10/15 €205,126 €211,892 +€6,766 +3.3%
Contributions 10/11 €18,600 €18,600 = 0.0%
Reserves 13 €185,860 €192,860 +€7,000 +3.8%
Distributable reserves 133 €185,860 €192,860 +€7,000 +3.8%
Profit (loss) carried forward 14 €666 €432 -€234 -35.1%
Amounts payable 17/49 €407,242 €318,192 -€89,050 -21.9%
Amounts payable after more than one year 17 €153,059 €106,441 -€46,618 -30.5%
Financial debts 170/4 €153,059 €106,441 -€46,618 -30.5%
Amounts payable within one year 42/48 €248,587 €206,994 -€41,593 -16.7%
Current portion of amounts payable after more than one year 42 €56,647 €46,618 -€10,029 -17.7%
Trade debts 44 €67,375 €70,839 +€3,464 +5.1%
Suppliers 440/4 €67,375 €70,839 +€3,464 +5.1%
Taxes, remuneration and social security 45 €39,669 €33,578 -€6,090 -15.4%
Taxes 450/3 €22,031 €13,336 -€8,696 -39.5%
Remuneration and social security 454/9 €17,637 €20,243 +€2,606 +14.8%
Other amounts payable 47/48 €84,896 €55,958 -€28,938 -34.1%
Accrued charges and deferred income 492/3 €5,596 €4,757 -€839 -15.0%
Remuneration, social security and pensions 62 €112,265 €127,771 +€15,506 +13.8%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €44,751 €44,842 +€91 +0.2%
Other operating charges 640/8 €2,616 €2,413 -€203 -7.8%
Non-recurring operating charges 66A - €1,159 +€1,159
Gross operating margin 9900 €233,827 €194,511 -€39,316 -16.8%
Operating profit (loss) 9901 €74,195 €18,326 -€55,869 -75.3%
Financial income 75/76B €1,184 €1,291 +€107 +9.0%
Recurring financial income 75 €1,184 €1,291 +€107 +9.0%
Financial charges 65/66B €11,996 €8,420 -€3,576 -29.8%
Recurring financial charges 65 €11,996 €8,420 -€3,576 -29.8%
Profit (loss) for the period before taxes 9903 €63,383 €11,196 -€52,186 -82.3%
Income taxes 67/77 €17,786 €3,597 -€14,189 -79.8%
Profit (loss) for the period 9904 €45,596 €7,599 -€37,997 -83.3%
Profit (loss) for the period to be appropriated 9905 €45,596 €7,599 -€37,997 -83.3%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€203,230 to €248,099

Midpoint €221,925 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €182,118
Capitalised earnings €224,343 to €314,080
Indication €203,230 to €248,099

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€211,892
Intangible fixed assets (21)
-€29,775
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€182,118

Capitalised earnings

net result for the year (9904)
2025
€7,599
excluding non-recurring income and charges
€8,758
2024
€45,596
2023
€39,871
2022
€42,189
excluding non-recurring income and charges
€44,956
2021
€29,874
excluding non-recurring income and charges
€30,054
Average result, excluding non-recurring income and charges
€31,408
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€224,343 / €261,733 / €314,080

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 15 November 2026 via checked.be.